Most cancer hallmark signaling pathways were significantly activated in tumor cells from EBV DNA Sero+ samples, such as IFN-mediated immune responses, P53 pathway, hypoxia, and inflammation-related pathways. The gene discussed is TP53; the disease is cancer.